APO Research
Talk to an analyst

APO RESEARCH · REPORT

Canine Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Canine Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025190 pages

Choose your research edition.

Industry ResearchCanine Vaccine Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Canine Vaccine Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Canine Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Canine Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Canine Vaccine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Canine Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Canine Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Canine Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Canine Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Canine Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Canine Vaccine include Biogenesis Bago, Boehringer Ingelheim, Durvet, NeoTech, Virbac, Pfizer, Jilin Five-Star Animal Health, JINHE and Wuhan Keqian Biology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Canine Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Canine Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Canine Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Canine Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Canine Vaccine Segment by Company

Biogenesis Bago

Boehringer Ingelheim

Durvet

NeoTech

Virbac

Pfizer

Jilin Five-Star Animal Health

JINHE

Wuhan Keqian Biology

SINOVAC

Elanco

Merck Animal Health

RuiPu Bio-Technology

Zoetis

CAHIC

Canine Vaccine Segment by Type

Core Vaccines

Non-Core Vaccines

Canine Vaccine Segment by Application

Puppies

Adult Dogs

Canine Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Canine Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Canine Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Canine Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Canine Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Canine Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Canine Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Canine Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Canine Vaccine Industry Trends Table 2. Canine Vaccine Industry Drivers Table 3. Canine Vaccine Industry Opportunities and Challenges Table 4. Canine Vaccine Industry Restraints Table 5. Global Canine Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Canine Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Canine Vaccine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Canine Vaccine Sales Market Share by Manufacturers Table 9. Global Canine Vaccine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Canine Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Canine Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Canine Vaccine Manufacturers, Product Type & Application Table 13. Global Canine Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Canine Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Core Vaccines Table 17. Major Manufacturers of Non-Core Vaccines Table 18. Global Canine Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Canine Vaccine Sales by Type (2021-2026) & (K Units) Table 20. Global Canine Vaccine Sales by Type (2027-2032) & (K Units) Table 21. Global Canine Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Canine Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Canine Vaccine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Canine Vaccine Revenue by Type (2021-2026) & (K Units) Table 25. Global Canine Vaccine Revenue by Type (2027-2032) & (K Units) Table 26. Global Canine Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Canine Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Puppies Table 29. Major Manufacturers of Adult Dogs Table 30. Global Canine Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Canine Vaccine Sales by Application (2021-2026) & (K Units) Table 32. Global Canine Vaccine Sales by Application (2027-2032) & (K Units) Table 33. Global Canine Vaccine Sales Market Share by Application (2021-2026) Table 34. Global Canine Vaccine Sales Market Share by Application (2027-2032) Table 35. Global Canine Vaccine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Canine Vaccine Revenue by Application (2021-2026) & (K Units) Table 37. Global Canine Vaccine Revenue by Application (2027-2032) & (K Units) Table 38. Global Canine Vaccine Revenue Market Share by Application (2021-2026) Table 39. Global Canine Vaccine Revenue Market Share by Application (2027-2032) Table 40. Global Canine Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Canine Vaccine Sales by Region (2021-2026) & (K Units) Table 42. Global Canine Vaccine Sales Market Share by Region (2021-2026) Table 43. Global Canine Vaccine Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Canine Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Canine Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Canine Vaccine Sales by Country (2021-2026) & (K Units) Table 47. North America Canine Vaccine Sales by Country (2027-2032) & (K Units) Table 48. Europe Canine Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Canine Vaccine Sales by Country (2021-2026) & (K Units) Table 50. Europe Canine Vaccine Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Canine Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Canine Vaccine Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Canine Vaccine Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Canine Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Canine Vaccine Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Canine Vaccine Sales by Country (2027-2032) & (K Units) Table 57. Global Canine Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Canine Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Canine Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Canine Vaccine Revenue Market Share by Region (2021-2026) Table 61. Global Canine Vaccine Revenue Market Share by Region (2027-2032) Table 62. Biogenesis Bago Company Information Table 63. Biogenesis Bago Business Overview Table 64. Biogenesis Bago Canine Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Biogenesis Bago Canine Vaccine Product Portfolio Table 66. Biogenesis Bago Recent Development Table 67. Boehringer Ingelheim Company Information Table 68. Boehringer Ingelheim Business Overview Table 69. Boehringer Ingelheim Canine Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Boehringer Ingelheim Canine Vaccine Product Portfolio Table 71. Boehringer Ingelheim Recent Development Table 72. Durvet Company Information Table 73. Durvet Business Overview Table 74. Durvet Canine Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Durvet Canine Vaccine Product Portfolio Table 76. Durvet Recent Development Table 77. NeoTech Company Information Table 78. NeoTech Business Overview Table 79. NeoTech Canine Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. NeoTech Canine Vaccine Product Portfolio Table 81. NeoTech Recent Development Table 82. Virbac Company Information Table 83. Virbac Business Overview Table 84. Virbac Canine Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Virbac Canine Vaccine Product Portfolio Table 86. Virbac Recent Development Table 87. Pfizer Company Information Table 88. Pfizer Business Overview Table 89. Pfizer Canine Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Pfizer Canine Vaccine Product Portfolio Table 91. Pfizer Recent Development Table 92. Jilin Five-Star Animal Health Company Information Table 93. Jilin Five-Star Animal Health Business Overview Table 94. Jilin Five-Star Animal Health Canine Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Jilin Five-Star Animal Health Canine Vaccine Product Portfolio Table 96. Jilin Five-Star Animal Health Recent Development Table 97. JINHE Company Information Table 98. JINHE Business Overview Table 99. JINHE Canine Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. JINHE Canine Vaccine Product Portfolio Table 101. JINHE Recent Development Table 102. Wuhan Keqian Biology Company Information Table 103. Wuhan Keqian Biology Business Overview Table 104. Wuhan Keqian Biology Canine Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Wuhan Keqian Biology Canine Vaccine Product Portfolio Table 106. Wuhan Keqian Biology Recent Development Table 107. SINOVAC Company Information Table 108. SINOVAC Business Overview Table 109. SINOVAC Canine Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. SINOVAC Canine Vaccine Product Portfolio Table 111. SINOVAC Recent Development Table 112. Elanco Company Information Table 113. Elanco Business Overview Table 114. Elanco Canine Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Elanco Canine Vaccine Product Portfolio Table 116. Elanco Recent Development Table 117. Merck Animal Health Company Information Table 118. Merck Animal Health Business Overview Table 119. Merck Animal Health Canine Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Merck Animal Health Canine Vaccine Product Portfolio Table 121. Merck Animal Health Recent Development Table 122. RuiPu Bio-Technology Company Information Table 123. RuiPu Bio-Technology Business Overview Table 124. RuiPu Bio-Technology Canine Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. RuiPu Bio-Technology Canine Vaccine Product Portfolio Table 126. RuiPu Bio-Technology Recent Development Table 127. Zoetis Company Information Table 128. Zoetis Business Overview Table 129. Zoetis Canine Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Zoetis Canine Vaccine Product Portfolio Table 131. Zoetis Recent Development Table 132. CAHIC Company Information Table 133. CAHIC Business Overview Table 134. CAHIC Canine Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. CAHIC Canine Vaccine Product Portfolio Table 136. CAHIC Recent Development Table 137. Key Raw Materials Table 138. Raw Materials Key Suppliers Table 139. Canine Vaccine Distributors List Table 140. Canine Vaccine Customers List Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Canine Vaccine Product Image Figure 2. Global Canine Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Canine Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Canine Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Canine Vaccine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Canine Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Core Vaccines Image Figure 9. Non-Core Vaccines Image Figure 10. Global Canine Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Canine Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Canine Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Canine Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Canine Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Canine Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Puppies Image Figure 17. Adult Dogs Image Figure 18. Global Canine Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Canine Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Canine Vaccine Sales Market Share by Application (2021-2032) Figure 21. Global Canine Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Canine Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Canine Vaccine Revenue Market Share by Application (2021-2032) Figure 24. North America Canine Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Canine Vaccine Sales Market Share by Country (2021-2032) Figure 26. U.S. Canine Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Canine Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Canine Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Canine Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Canine Vaccine Sales Market Share by Country (2021-2032) Figure 31. Germany Canine Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Canine Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Canine Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Canine Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Canine Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Canine Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Canine Vaccine Sales Market Share by Country (2021-2032) Figure 38. China Canine Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Canine Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Canine Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Canine Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Canine Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Canine Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Canine Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Canine Vaccine Sales Market Share by Country (2021-2032) Figure 46. Brazil Canine Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Canine Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Canine Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Canine Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Canine Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Canine Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Canine Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Canine Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Canine Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Canine Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Canine Vaccine Revenue (2021-2032) & (US$ Million) Figure 57. North America Canine Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Canine Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. Europe Canine Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Canine Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Canine Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Canine Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Canine Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Canine Vaccine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Canine Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Core Vaccines
  • Non-Core Vaccines
Applications
  • Puppies
  • Adult Dogs
Companies covered
  • Biogenesis Bago
  • Boehringer Ingelheim
  • Durvet
  • NeoTech
  • Virbac
  • Pfizer
  • Jilin Five-Star Animal Health
  • JINHE
  • Wuhan Keqian Biology
  • SINOVAC
  • Elanco
  • Merck Animal Health
  • RuiPu Bio-Technology
  • Zoetis
  • CAHIC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Canine Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Canine Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Canine Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Canine Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Canine Vaccine Market Dynamics
  1. 2.1 Canine Vaccine Industry Trends
  2. 2.2 Canine Vaccine Industry Drivers
  3. 2.3 Canine Vaccine Industry Opportunities and Challenges
  4. 2.4 Canine Vaccine Industry Restraints
3 Canine Vaccine Market by Manufacturers
  1. 3.1 Global Canine Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Canine Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Canine Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Canine Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Canine Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Canine Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Canine Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Canine Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Canine Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Canine Vaccine Tier 1, Tier 2, and Tier 3
4 Canine Vaccine Market by Type
  1. 4.1 Canine Vaccine Type Introduction
  2. 4.1.1 Core Vaccines
  3. 4.1.2 Non-Core Vaccines
  4. 4.2 Global Canine Vaccine Sales by Type
  5. 4.2.1 Global Canine Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Canine Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Canine Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Canine Vaccine Revenue by Type
  9. 4.3.1 Global Canine Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Canine Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Canine Vaccine Revenue Market Share by Type (2021-2032)
5 Canine Vaccine Market by Application
  1. 5.1 Canine Vaccine Application Introduction
  2. 5.1.1 Puppies
  3. 5.1.2 Adult Dogs
  4. 5.2 Global Canine Vaccine Sales by Application
  5. 5.2.1 Global Canine Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Canine Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Canine Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Canine Vaccine Revenue by Application
  9. 5.3.1 Global Canine Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Canine Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Canine Vaccine Revenue Market Share by Application (2021-2032)
6 Global Canine Vaccine Sales by Region
  1. 6.1 Global Canine Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Canine Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Canine Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Canine Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Canine Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Canine Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Canine Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Canine Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Canine Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Canine Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Canine Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Canine Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Canine Vaccine Revenue by Region
  1. 7.1 Global Canine Vaccine Revenue by Region
  2. 7.1.1 Global Canine Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Canine Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Canine Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Canine Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Canine Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Canine Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Canine Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Canine Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Canine Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Canine Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Canine Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Canine Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Biogenesis Bago
  2. 8.1.1 Biogenesis Bago Company Information
  3. 8.1.2 Biogenesis Bago Business Overview
  4. 8.1.3 Biogenesis Bago Canine Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Biogenesis Bago Canine Vaccine Product Portfolio
  6. 8.1.5 Biogenesis Bago Recent Developments
  7. 8.2 Boehringer Ingelheim
  8. 8.2.1 Boehringer Ingelheim Company Information
  9. 8.2.2 Boehringer Ingelheim Business Overview
  10. 8.2.3 Boehringer Ingelheim Canine Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Boehringer Ingelheim Canine Vaccine Product Portfolio
  12. 8.2.5 Boehringer Ingelheim Recent Developments
  13. 8.3 Durvet
  14. 8.3.1 Durvet Company Information
  15. 8.3.2 Durvet Business Overview
  16. 8.3.3 Durvet Canine Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Durvet Canine Vaccine Product Portfolio
  18. 8.3.5 Durvet Recent Developments
  19. 8.4 NeoTech
  20. 8.4.1 NeoTech Company Information
  21. 8.4.2 NeoTech Business Overview
  22. 8.4.3 NeoTech Canine Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 NeoTech Canine Vaccine Product Portfolio
  24. 8.4.5 NeoTech Recent Developments
  25. 8.5 Virbac
  26. 8.5.1 Virbac Company Information
  27. 8.5.2 Virbac Business Overview
  28. 8.5.3 Virbac Canine Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Virbac Canine Vaccine Product Portfolio
  30. 8.5.5 Virbac Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Canine Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Canine Vaccine Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Jilin Five-Star Animal Health
  38. 8.7.1 Jilin Five-Star Animal Health Company Information
  39. 8.7.2 Jilin Five-Star Animal Health Business Overview
  40. 8.7.3 Jilin Five-Star Animal Health Canine Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Jilin Five-Star Animal Health Canine Vaccine Product Portfolio
  42. 8.7.5 Jilin Five-Star Animal Health Recent Developments
  43. 8.8 JINHE
  44. 8.8.1 JINHE Company Information
  45. 8.8.2 JINHE Business Overview
  46. 8.8.3 JINHE Canine Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 JINHE Canine Vaccine Product Portfolio
  48. 8.8.5 JINHE Recent Developments
  49. 8.9 Wuhan Keqian Biology
  50. 8.9.1 Wuhan Keqian Biology Company Information
  51. 8.9.2 Wuhan Keqian Biology Business Overview
  52. 8.9.3 Wuhan Keqian Biology Canine Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Wuhan Keqian Biology Canine Vaccine Product Portfolio
  54. 8.9.5 Wuhan Keqian Biology Recent Developments
  55. 8.10 SINOVAC
  56. 8.10.1 SINOVAC Company Information
  57. 8.10.2 SINOVAC Business Overview
  58. 8.10.3 SINOVAC Canine Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 SINOVAC Canine Vaccine Product Portfolio
  60. 8.10.5 SINOVAC Recent Developments
  61. 8.11 Elanco
  62. 8.11.1 Elanco Company Information
  63. 8.11.2 Elanco Business Overview
  64. 8.11.3 Elanco Canine Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Elanco Canine Vaccine Product Portfolio
  66. 8.11.5 Elanco Recent Developments
  67. 8.12 Merck Animal Health
  68. 8.12.1 Merck Animal Health Company Information
  69. 8.12.2 Merck Animal Health Business Overview
  70. 8.12.3 Merck Animal Health Canine Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Merck Animal Health Canine Vaccine Product Portfolio
  72. 8.12.5 Merck Animal Health Recent Developments
  73. 8.13 RuiPu Bio-Technology
  74. 8.13.1 RuiPu Bio-Technology Company Information
  75. 8.13.2 RuiPu Bio-Technology Business Overview
  76. 8.13.3 RuiPu Bio-Technology Canine Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 RuiPu Bio-Technology Canine Vaccine Product Portfolio
  78. 8.13.5 RuiPu Bio-Technology Recent Developments
  79. 8.14 Zoetis
  80. 8.14.1 Zoetis Company Information
  81. 8.14.2 Zoetis Business Overview
  82. 8.14.3 Zoetis Canine Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Zoetis Canine Vaccine Product Portfolio
  84. 8.14.5 Zoetis Recent Developments
  85. 8.15 CAHIC
  86. 8.15.1 CAHIC Company Information
  87. 8.15.2 CAHIC Business Overview
  88. 8.15.3 CAHIC Canine Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 CAHIC Canine Vaccine Product Portfolio
  90. 8.15.5 CAHIC Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Canine Vaccine Value Chain Analysis
  2. 9.1.1 Canine Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Canine Vaccine Production Mode & Process
  6. 9.2 Canine Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Canine Vaccine Distributors
  9. 9.2.3 Canine Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst